Cite
HARVARD Citation
Tsai, H. et al. (2021). NF45/NF90‐mediated rDNA transcription provides a novel target for immunosuppressant development. EMBO molecular medicine. 13 (3), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tsai, H. et al. (2021). NF45/NF90‐mediated rDNA transcription provides a novel target for immunosuppressant development. EMBO molecular medicine. 13 (3), p. n/a. [Online].